Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience

Abstract Rationale & Objective The approved therapeutic indication for immune checkpoint inhibitors (CPIs) are rapidly expanding including treatment in the adjuvant setting, the immune related toxicities associated with CPI can limit the efficacy of these agents. The literature on the nephrotoxi...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Omar Mamlouk, Umut Selamet, Shana Machado, Maen Abdelrahim, William F. Glass, Amanda Tchakarov, Lillian Gaber, Amit Lahoti, Biruh Workeneh, Sheldon Chen, Jamie Lin, Noha Abdel-Wahab, Jean Tayar, Huifang Lu, Maria Suarez-Almazor, Nizar Tannir, Cassian Yee, Adi Diab, Ala Abudayyeh
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMJ Publishing Group 2019-01-01
Saila:Journal for ImmunoTherapy of Cancer
Gaiak:
Checkpoint inhibitors
Immunotherapy
Glomerulonephritis
Acute tubulointerstitial nephritis
Sarrera elektronikoa:http://link.springer.com/article/10.1186/s40425-018-0478-8
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak